AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteBMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity.
More Information Supplier PageBMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity.
More Information Supplier PageBMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity.
More Information Supplier PageBMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity.
More Information Supplier PageBMS-927711 is a potent, selective, competitive human calcitonin gene-related peptide (CGRP) receptor antagonist that has shown in vivo efficacy without vasoconstrictor effect.
More Information Supplier PageBMS-927711 is a potent, selective, competitive human calcitonin gene-related peptide (CGRP) receptor antagonist that has shown in vivo efficacy without vasoconstrictor effect.
More Information Supplier PageBMS-927711 is a potent, selective, competitive human calcitonin gene-related peptide (CGRP) receptor antagonist that has shown in vivo efficacy without vasoconstrictor effect.
More Information Supplier PageBMS-927711 is a potent, selective, competitive human calcitonin gene-related peptide (CGRP) receptor antagonist that has shown in vivo efficacy without vasoconstrictor effect.
More Information Supplier PageBMS303141 is a potent inhibitor of ATP citrate lyase (ACL). BMS303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 ??M, and lowers plasma triglycerides in a murine hyperlipdemia model.
More Information Supplier PageBMS303141 is a potent inhibitor of ATP citrate lyase (ACL). BMS303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 ??M, and lowers plasma triglycerides in a murine hyperlipdemia model.
More Information Supplier PageBMS303141 is a potent inhibitor of ATP citrate lyase (ACL). BMS303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 ??M, and lowers plasma triglycerides in a murine hyperlipdemia model.
More Information Supplier PageBMS303141 is a potent inhibitor of ATP citrate lyase (ACL). BMS303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 ??M, and lowers plasma triglycerides in a murine hyperlipdemia model.
More Information Supplier PageBMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator, and this compound has been advanced to clinical trials for the treatment of age-related functional decline.
More Information Supplier PageBMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator, and this compound has been advanced to clinical trials for the treatment of age-related functional decline.
More Information Supplier PageBMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator, and this compound has been advanced to clinical trials for the treatment of age-related functional decline.
More Information Supplier PageBMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator, and this compound has been advanced to clinical trials for the treatment of age-related functional decline.
More Information Supplier PageBMX-IN-1 is a highly selective and potent irreversible inhibitor which target the cysteine residue in the BMX ATP binding domain.
More Information Supplier PageBMX-IN-1 is a highly selective and potent irreversible inhibitor which target the cysteine residue in the BMX ATP binding domain.
More Information Supplier PageBMX-IN-1 is a highly selective and potent irreversible inhibitor which target the cysteine residue in the BMX ATP binding domain.
More Information Supplier PageBMY 7378 is a 5-HT1A partial agonist and high affinity ??1D adrenoceptor antagonist.
More Information Supplier PageBMY 7378 is a 5-HT1A partial agonist and high affinity ??1D adrenoceptor antagonist.
More Information Supplier PageBMY 7378 is a 5-HT1A partial agonist and high affinity ??1D adrenoceptor antagonist.
More Information Supplier PageBMY 7378 is a 5-HT1A partial agonist and high affinity ??1D adrenoceptor antagonist.
More Information Supplier PageBNP (1-32), human is a brain natriuretic peptide secreted by the human heart in response to cardiac volume or pressure.
More Information Supplier PageBNP (1-32), human is a brain natriuretic peptide secreted by the human heart in response to cardiac volume or pressure.
More Information Supplier PageBNP (1-32), human is a brain natriuretic peptide secreted by the human heart in response to cardiac volume or pressure.
More Information Supplier PageBNS-22 is a potent small molecule inhibitor of Topo II (IC50 2.8 M and 0.42 M for Topo II alpha and Topo II beta, respectively).
More Information Supplier PageBNS-22 is a potent small molecule inhibitor of Topo II (IC50 2.8 M and 0.42 M for Topo II alpha and Topo II beta, respectively).
More Information Supplier PageBNS-22 is a potent small molecule inhibitor of Topo II (IC50 2.8 M and 0.42 M for Topo II alpha and Topo II beta, respectively).
More Information Supplier PageBoceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
More Information Supplier PageBoceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
More Information Supplier PageBoceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
More Information Supplier PageBoceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
More Information Supplier PageBoldenone undecylenate is a synthetic steroid which has a similar effect as the natural steroid testosterone, it is frequently used in veterinary medicine, though it is also used in humans.
More Information Supplier PageBoldenone undecylenate is a synthetic steroid which has a similar effect as the natural steroid testosterone, it is frequently used in veterinary medicine, though it is also used in humans.
More Information Supplier PageBoldenone undecylenate is a synthetic steroid which has a similar effect as the natural steroid testosterone, it is frequently used in veterinary medicine, though it is also used in humans.
More Information Supplier PageBombesin is a neuropeptide with many biological effects including hormone release, stimulation of pancreatic enzyme secretion, inhibition of gastric emptying and modulation of gastric acid secretion.
More Information Supplier PageBombesin is a neuropeptide with many biological effects including hormone release, stimulation of pancreatic enzyme secretion, inhibition of gastric emptying and modulation of gastric acid secretion.
More Information Supplier PageBombesin is a neuropeptide with many biological effects including hormone release, stimulation of pancreatic enzyme secretion, inhibition of gastric emptying and modulation of gastric acid secretion.
More Information Supplier Page
